Mother, 19, who was diagnosed with untreatable brain cancer months before giving birth dies
Dana Scatton, of Pennsylvania, was seven months pregnant in December 2017 when a brain scan revealed she had diffuse intrinsic pontine glioma (DIPG). (Source: the Mail online | Health)
Source: the Mail online | Health - April 25, 2019 Category: Consumer Health News Source Type: news

Virtual reality engages patients more than CT, booklets
Patients with an abdominal aortic aneurysm were more engaged and had a better...Read more on AuntMinnie.comRelated Reading: 4 practical applications of VR, AR in radiology SIR: Virtual reality beats fluoroscopy for catheter placement VR, AR elevate radiologists' value in future of medicine Virtual reality may help plan, guide glioma resection VR software may increase MRI segmentation efficiency (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 25, 2019 Category: Radiology Source Type: news

How Common Are Brain Tumors Seen in Spasmus Nutans?
Discussion Nystagmus is periodic eye movement that is involuntary where there is a slow drift of fixation. The slow drift can be followed by a fast saccade back to fixation. The pathological movement is the slow phase, but nystagmus is described by the fast phase (i.e. horizontal nystagmus, vertical nystagmus). Spasmus nutans (SN) is a movement disorder that is rare. The classic triad includes nystagmus, head bobbing or titubation, and torticollis, with these problems being in the absence of any ophthalmological or neurological condition. Onset is in the first year of life but ranges from 6-36 months. Time to resolution ...
Source: PediatricEducation.org - April 15, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

How Commonly Are Brain Tumors Seen in Spasmus Nutans?
Discussion Nystagmus is periodic eye movement that is involuntary where there is a slow drift of fixation. The slow drift can be followed by a fast saccade back to fixation. The pathological movement is the slow phase, but nystagmus is described by the fast phase (i.e. horizontal nystagmus, vertical nystagmus). Spasmus nutans (SN) is a movement disorder that is rare. The classic triad includes nystagmus, head bobbing or titubation, and torticollis, with these problems being in the absence of any ophthalmological or neurological condition. Onset is in the first year of life but ranges from 6-36 months. Time to resolution ...
Source: PediatricEducation.org - April 15, 2019 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

How cost-effective is intraoperative MRI for gliomas?
Using a simulated clinical decision analysis model, researchers from the University...Read more on AuntMinnie.comRelated Reading: Workflow optimization cuts MRI turnaround time Imaging analytics platform optimizes MRI operations MRA is cost-effective for kidney disease-related aneurysms Study reveals steep cost of delaying stroke treatment MRI for knee pain adds cost with negligible benefit (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 2, 2019 Category: Radiology Source Type: news

Clinical trial finds therapy to be well-tolerated in patients with aggressive brain tumour
A phase I clinical trial that set out to assess the safety of a new combination therapy for a type of aggressive brain tumour has found the treatment to be well tolerated in patients. The trial used a treatment combination of ADI-PEG20, pemetrexed and cisplatin, which showed encouraging efficacy in patients with recurrent high-grade gliomas (HGGs), a disease for which little progress has been made over the last few decades. (Source: World Pharma News)
Source: World Pharma News - March 29, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

SIR: Virtual reality beats fluoroscopy for catheter placement
Virtual reality may be a safer, more time-efficient alternative to conventional...Read more on AuntMinnie.comRelated Reading: VR, AR elevate radiologists' value in future of medicine Virtual reality may help plan, guide glioma resection 3D printing gives pediatric heart surgery a boost Virtual reality, 3D printing resolve obscure lung cancer Virtual reality adds depth to brain aneurysm diagnosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 26, 2019 Category: Radiology Source Type: news

New drug combination shows promise for common pediatric brain tumor
(Johns Hopkins Medicine) A new combination treatment aimed at resistant and recurrent low-grade gliomas slowed tumor growth and killed tumor cells in laboratory and mouse models. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 21, 2019 Category: International Medicine & Public Health Source Type: news

Augmented reality cultivates early radiology education
An interactive educational course that uses augmented reality technology to...Read more on AuntMinnie.comRelated Reading: VR, AR elevate radiologists' value in future of medicine AR aids image-guided spinal procedures on live patients AR improves operative view for robotic thyroid surgery AR, 3D printing make headway in patient education Virtual reality may help plan, guide glioma resection (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 11, 2019 Category: Radiology Source Type: news

VR, AR elevate radiologists' value in future of medicine
How can virtual reality (VR) and augmented reality (AR) help radiologists advance...Read more on AuntMinnie.comRelated Reading: AR aids image-guided spinal procedures on live patients AR improves operative view for robotic thyroid surgery Virtual reality may help plan, guide glioma resection VR, AR may revamp cardiovascular imaging Virtual reality adds depth to brain aneurysm diagnosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 4, 2019 Category: Radiology Source Type: news

Gadolinium breast MRI screening OK for healthy women
VIENNA - Healthy women at high risk for developing breast cancer should have...Read more on AuntMinnie.comRelated Reading: Video from ECR 2019: Alexander Radbruch on gadolinium debate Gadolinium in gliomas, adjacent tissue raises questions German study may offer new way to detect gadolinium Patients report long-term gadolinium presence in urine Gadolinium accumulation might be more widespread than thought (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 4, 2019 Category: Radiology Source Type: news

Promising strategy to fight the most deadly brain tumor in children
(Ann& Robert H. Lurie Children's Hospital of Chicago) A study published in Nature Communications found that an inhibitor of an enzyme called ACVR1 slows tumor growth and increases survival in an animal model of diffuse intrinsic pontine glioma (DIPG) -- the most deadly brain tumor in children. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 4, 2019 Category: Cancer & Oncology Source Type: news

Super-enhancers: novel target for pancreatic ductal adenocarcinoma
(Rapamycin Press) Among many pathways of cancer progression that PDAC relies on, anomalous activation of the sonic hedgehog pathway has shown in a variety of human cancers, including, basal cell carcinoma, malignant gliomas, medulloblastoma, leukemias, and cancers of the breast, lung, pancreas, and prostate. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 26, 2019 Category: Cancer & Oncology Source Type: news

Blocking DNA repair restores sensitivity of brain tumors to treatment in mice
Researchers found that blocking DNA repair made gliomas, a type of deadly brain tumor, more responsive to radiation therapy in mice. The study suggests possible treatment strategies. (Source: NIH Research Matters from the National Institutes of Health (NIH))
Source: NIH Research Matters from the National Institutes of Health (NIH) - February 26, 2019 Category: Consumer Health News Source Type: news

Study unveils a blueprint for treating a deadly brain tumor
(NIH/National Institute of Neurological Disorders and Stroke) In a study of mice and human brain tumors researchers at the University of the Michigan, Ann Arbor, searched for new treatments by exploring the reasons why some patients with gliomas live remarkably longer than others. The results suggested that certain patients' tumor cells are less aggressive and much better at repairing DNA than others but are difficult to kill with radiation. The researchers then showed that combining radiation therapy with cancer drugs designed to block DNA repair may be an effective treatment strategy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 19, 2019 Category: Cancer & Oncology Source Type: news

Gadolinium in gliomas, adjacent tissue raises questions
Researchers have discovered the presence of gadolinium from MRI contrast in...Read more on AuntMinnie.comRelated Reading: German study may offer new way to detect gadolinium Gadolinium accumulation might be more widespread than thought AI may help in fight against gadolinium deposition Is gadolinium deposition disease really a disease? (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 12, 2019 Category: Radiology Source Type: news

Burn-induced neuroepithelial changes as a delayed cause of mortality in major burns: a case report and literature review - Obeid DA, Alhujayri AK, Aldekhayel S.
BACKGROUND: Mortality in major burns is caused mainly by multisystem organ failure. Brain lesions in burn patients are rare and predominantly traumatic in nature. Here, we present an unusual case of burn-induced glioma causing rapid neurological deteriorat... (Source: SafetyLit)
Source: SafetyLit - February 1, 2019 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

Apatinib Case Study Uncovers Potential Mesothelioma Treatment
Doctors in China may have uncovered an effective second- or third-line treatment option for patients with malignant pleural mesothelioma. Dr. RongQin Meng, an oncologist at 363 Hospital in Cheng Du, said the investigational drug Apatinib (rivoceranib) could become part of a much-needed advance in mesothelioma treatment. After first- and second-line chemotherapy combinations had failed to slow tumor growth in a 58-year-old woman, Apatinib provided a five-month progression-free survival. “I was surprised at the result,” Meng told The Mesothelioma Center at Asbestos.com. “After taking the drug, the quality o...
Source: Asbestos and Mesothelioma News - January 31, 2019 Category: Environmental Health Authors: Daniel King Source Type: news

FET-PET adds 'relevant' info to pediatric cancer cases
Thanks to its high specificity, fluoroethyl-tyrosine (FET)-PET can help confirm...Read more on AuntMinnie.comRelated Reading: Ga-68 PSMA-11 PET/MRI benefits prostate cancer patients SNMMI: FET-PET could have answers for brainstem glioma SNMMI: FET-PET aids pediatric brain cancer patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 30, 2019 Category: Radiology Source Type: news

Synodos does it again: Breaking barriers to solve the 'impossible' problems
(Children's Tumor Foundation) Treatment for low-grade gliomas in patients living with neurofibromatosis type 1 are now one step closer thanks to recent research discoveries initiated and funded by the Children's Tumor Foundation. The Foundation's SYNODOS consortium has just recently been published in Nature Medicine, showing that immunotherapy has the potential to impact gliomas. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 27, 2018 Category: Cancer & Oncology Source Type: news

Artificial activation of cancer cells to destroy them
(Far Eastern Federal University) This risky method of anti-cancer therapy was suggested by scientists of Far Eastern Federal University (FEFU). Their review of mechanisms for molecular activation of stem cells of gliomas (most widely-spread brain tumors) was approved for publishing in the Frontiers in Cellular Neuroscience journal. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 26, 2018 Category: International Medicine & Public Health Source Type: news

Promising Glioma Therapy Options
Dr. James Perry speaks withCancer Network about glioma therapy options and the future of brain cancer treatment. (Source: CancerNetwork)
Source: CancerNetwork - December 22, 2018 Category: Cancer & Oncology Authors: James Perry, MD Source Type: news

AR improves operative view for robotic thyroid surgery
Researchers from South Korea have developed a technique to enhance the safety...Read more on AuntMinnie.comRelated Reading: AR, 3D printing make headway in patient education Virtual reality may help plan, guide glioma resection Augmented reality heightens accuracy of brain procedure Augmented reality guides orthopedic surgery SIR: Holography platform boosts reader confidence for aneurysms (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 13, 2018 Category: Radiology Source Type: news

FDA to review Blue Earth's Axumin for brain cancer
The U.S. Food and Drug Administration (FDA) has accepted molecular imaging...Read more on AuntMinnie.comRelated Reading: Blue Earth study reports Axumin can aid glioma diagnosis Blue Earth promotes results for PET/CT agent Blue Earth expands PSMA-PET/CT imaging portfolio Blue Earth touts addition of Axumin to NCCN guidelines Blue Earth highlights Axumin clinical results at ASTRO (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 11, 2018 Category: Radiology Source Type: news

'Don't come back and don't bring any friends!' Cancer patient waves goodbye to his brain tumour
James Hinnigan, 39, of Wigan, Greater Manchester, underwent pioneering surgery to remove his stage two glioma while taking part in a clinical trial at Charing Cross Hospital in 2016. (Source: the Mail online | Health)
Source: the Mail online | Health - December 6, 2018 Category: Consumer Health News Source Type: news

Liquid Biopsy Can Assess Tx Response of Peds Brain Tumors
THURSDAY, Nov. 29, 2018 -- A liquid biopsy using blood or cerebrospinal fluid (CSF) can effectively quantify changes in mutation levels among pediatric patients being treated for diffuse midline gliomas (DMGs), according to a study recently... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 29, 2018 Category: Pharmaceuticals Source Type: news

Brain tumor patient, 5, astonishes doctors by walking and talking
Rebecca Roper, five, from Enid, Oklahoma, was diagnosed with a tumor known as a glioma on her brainstem in summer 2017. Doctors were unsure if she would ever walk again. (Source: the Mail online | Health)
Source: the Mail online | Health - November 26, 2018 Category: Consumer Health News Source Type: news

Blue Earth study reports Axumin can aid glioma diagnosis
Molecular imaging firm Blue Earth Diagnostics presented new results from a...Read more on AuntMinnie.comRelated Reading: Blue Earth promotes results for PET/CT agent Blue Earth expands PSMA-PET/CT imaging portfolio Blue Earth touts addition of Axumin to NCCN guidelines Blue Earth highlights Axumin clinical results at ASTRO Blue Earth touts Axumin reader training results (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 20, 2018 Category: Radiology Source Type: news

New drug discovery could halt spread of brain cancer
(Virginia Tech) A team of researchers at Virginia Tech may have found a solution to stopping the spread of glioblastoma with a new drug and cancer treatment method. This work is part of a five-year research grant project across multiple universities, examining the role of interstitial fluid flow in spreading glioma cells through the brain. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 19, 2018 Category: International Medicine & Public Health Source Type: news

Do Bigger Brains Contribute to More Cancer?
New research published inNeuro-Oncology examines the controversial link between intracranial volume and high-grade glioma. (Source: CancerNetwork)
Source: CancerNetwork - November 17, 2018 Category: Cancer & Oncology Authors: Naveed Saleh, MD, MS Source Type: news

Cognitive decline -- radiation -- brain tumor prevented by temporarily shutting down immune response
(University of California - San Francisco) In a new study published Nov. 13 in the journal eLife, UC San Francisco scientists report the first animal model of glioma -- the most aggressive and most common form of brain cancer in the US -- that can also be used to study the long-term effects of radiation therapy in tumor-bearing brains. Using this mouse model, the researchers showed that a drug that temporarily suppresses a key component of the brain's immune system can prevent radiation-associated cognitive decline. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 13, 2018 Category: International Medicine & Public Health Source Type: news

Fluorescence Can ID High - Grade Glioma During Sx for Brain Tumor
Visible fluorescence shows presence of high - grade glioma cells within tumor mass during surgery (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 6, 2018 Category: Cancer & Oncology Tags: Neurology, Oncology, Pathology, Radiology, Surgery, Conference News, Source Type: news

Fluorescence Can ID High-Grade Glioma During Sx for Brain Tumor
TUESDAY, Nov. 6, 2018 -- The presence of visible fluorescence can serve as an intraoperative diagnostic surgical biomarker of high-grade glioma within a brain tumor, according to a study presented at the 2018 National Cancer Research Institute... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 6, 2018 Category: Pharmaceuticals Source Type: news

CBD Bombshell: Cannabis approved by the FDA for treatment of brain and spinal cord glioma cancer tumors
(Natural News) This is huge. The FDA just granted orphan drug designation (ODD) to Insys Therapeutics for its pharmaceutical-grade, proprietary cannabidiol (CBD) product for treating cancer tumors in humans. Although glioma tumors affect less than 200,000 Americans, this FDA approval sets a precedent for natural remedies, and could lead to a revolutionary way to legally... (Source: NaturalNews.com)
Source: NaturalNews.com - October 24, 2018 Category: Consumer Health News Source Type: news

Liquid Biopsy May Reveal Treatment Response in Pediatric Brain Tumors Liquid Biopsy May Reveal Treatment Response in Pediatric Brain Tumors
In children with diffuse midline glioma (DMG), liquid biopsy based on analyses of circulating tumor DNA (ctDNA) in cerebral spinal fluid (CSF) or plasma shows promise for detecting mutational load and may serve as tool for assessing tumor response to treatment, researchers say.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - October 17, 2018 Category: Pathology Tags: Hematology-Oncology News Source Type: news

Human Brain Microvascular Endothelial Cell in Action
Recent PubsOur HumanBrain Microvascular Endothelial Cells (HBMECs) are known for the performance in drug discovery and tox assays. These 21-CFR compliant cells are used in the " blood side " of our3-D BBB Models.Shavali Shaik, Bridget Kennis, Shinji Maegawa, Keri Schadler, Yang Yanwen, Keri Callegari, Rishi R. Lulla, Stewart Goldman, Javad Nazarian, Veena Rajaram, Jason Fangusaro, and Vidya Gopalakrishnan. (2018).REST upregulates gremlin to modulate diffuse intrinsic pontine glioma vasculature. Oncotarget. 2018 Jan 12; 9(4): 5233 –5250. doi: 10.18632/oncotarget.23750 Hu et al. (2016). Epigenetic Activa...
Source: Neuromics - September 20, 2018 Category: Neuroscience Tags: Blood Brain Barrier Blood Brain Barrier Models brain microvascular endothelial cells HBMECs human brain microvascular Source Type: news

Researchers to study brain cancer with Department of Defense funding
(Henry Ford Health System) Henry Ford Health System's Department of Neurosurgery was awarded a $600,000 grant by the Department of Defense to study the genetic makeup of gliomas, a type of brain cancer, in hope of identifying new therapies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 18, 2018 Category: Cancer & Oncology Source Type: news

The boy whose clumsiness turned out to be cancer
Atticus Feduchin-Pate, from Whitchurch in Hampshire, has been diagnosed with a terminal high-grade cancer called diffuse intrinsic potine glioma which cannot be operated on. (Source: the Mail online | Health)
Source: the Mail online | Health - September 6, 2018 Category: Consumer Health News Source Type: news

Non-Hispanic White Patients Have Higher Glioma Incidence Non-Hispanic White Patients Have Higher Glioma Incidence
Dr Laurie Barclay comments on a study that aimed to quantify the differences in incidence and survival in adults with glioma by race or ethnicity.Medscape Neurology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 23, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery Viewpoint Source Type: news

Georgetown releases cache of brain cancer data
Georgetown Lombardi Comprehensive Cancer Center has released a set of brain...Read more on AuntMinnie.comRelated Reading: FLT-PET points toward survival for glioblastoma patients SNMMI: FET-PET could have answers for brainstem glioma PET/CT helps assess pediatric brain tumor therapy Brain MRI surprises with incidental findings SNMMI: FDOPA-PET/MRI monitors pediatric brain tumors (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 15, 2018 Category: Radiology Source Type: news

Researchers use microparticles for targeted delivery of brain cancer therapy
Credit: Christine Daniloff/MIT A team of researchers from Brigham & Women’s Hospital, Mass. Institute of Technology and Mass. General Hospital demonstrated that localizing the delivery of NAMPT inhibitors can extend survival in a mouse model of glioma, according to a paper published this week in the Proceedings of the National Academy of Sciences. The scientists created a test to check for a mutation linked to glioma and implanted microparticles that slowly elute drug over the course of several days or even weeks to treat the brain cancer. Get the full story at our sister site, ...
Source: Mass Device - August 7, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Oncology Pharmaceuticals Research & Development Brigham & Women's Hospital Massachusetts General Hospital Massachusetts Institute of Technology Source Type: news

A targeted approach to treating glioma
(Massachusetts Institute of Technology) Researchers from MIT, Brigham and Women's Hospital, and Massachusetts General Hospital have developed a new way to treat low-grade glioma. They devised a test that can rapidly check for the IDH mutation during brain surgery, and if the mutation is present, they can implant microparticles that gradually release an IDH-targeted drug over several days or weeks. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - August 6, 2018 Category: Biology Source Type: news

Rapid diagnostic coupled with local therapy developed for brain tumors
(Brigham and Women's Hospital) Working together, researchers from Brigham and Women's Hospital (BWH) and neurosurgeons from Massachusetts General Hospital (MGH), along with colleagues at MIT, are designing a new, rapid molecular diagnostic and sustained release therapeutic that could be deployed during brain surgery to treat gliomas and prevent their return. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 6, 2018 Category: Cancer & Oncology Source Type: news

Rapid Diagnostic Coupled with Local Therapy Developed for Brain Tumors
Interdisciplinary team develops rapid molecular diagnostic coupled to sustained release therapeutic to treat gliomas during surgery (Source: BWH News)
Source: BWH News - August 6, 2018 Category: Hospital Management Source Type: news

Chinese goldthread might offer the ideal treatment for people with brain cancer
(Natural News) Roughly sixty percent of all brain cancer are gliomas, a tumor that starts in the glial cells of the brain or the spine. There are many different grades of gliomas; each describing a variance in growth potential and aggressiveness. Regardless, conventional therapies involving radiation and chemotherapy drugs have been shown to be inconsistent... (Source: NaturalNews.com)
Source: NaturalNews.com - July 31, 2018 Category: Consumer Health News Source Type: news

FLT-PET points toward survival for glioblastoma patients
PET scans with the radiotracer F-18 fluorothymidine (FLT) can help determine...Read more on AuntMinnie.comRelated Reading: SNMMI: PET, MRI may predict pediatric brain tumor outcomes FDG-PET/CT beats FLT-PET/CT for differentiated thyroid cancer FLT-PET could help predict outcome in head and neck cancer JNM: FLT-PET aids prognosis of glioma patients FLT-PET helps predicts cancer therapy results (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 26, 2018 Category: Radiology Source Type: news

TGen opens DIPG tissue donation portal to accelerate research
(The Translational Genomics Research Institute) A tissue donation portal opened today at TGen, which will advance research towards new treatments for an aggressive brain cancer that mostly strikes young children. This new portal will accelerate the ability of families of children with DIPG -- or Diffuse Intrinsic Pontine Glioma -- to help TGen build a tissue bank that will aid researchers in their investigations of this rare and currently incurable disease that strikes about 350 children in the US each year. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - July 17, 2018 Category: Cancer & Oncology Source Type: news

Glioma Incidence, Survival in US Adults Vary by Ethnicity Glioma Incidence, Survival in US Adults Vary by Ethnicity
The incidence and survival rates of glioma in U.S. adults vary greatly by race or ethnicity, new research suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 13, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news